Kellokumpu-Lehtinen, Pirkko Liisa
University Hospital of Tampere,
Finland
2024 Rank: 133450
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Urology & Nephrology
Rank in SubField 1: 5061 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 133450 | 143438 |
| Total Cites | 11001 | 12239 |
| H-index | 49 | 52 |
| Hm-index | 15 | 16 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 23 | 23 |
| Number of Single+First Authored Papers | 52 | 52 |
| Total Cites to Single+First Authored Papers | 522 | 553 |
| Number of Single+First+Last Authored Papers | 157 | 157 |
| Total Cites to Single+First+Last Authored Papers | 3135 | 3357 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 10127 | 10990 |
| Ratio of Total Citations to Distinct Citing Papers | 1.09 | 1.11 |
| Self-Citation Percentage |
10.12%
|
|
Kellokumpu-Lehtinen, Pirkko Liisa
Tampere University,
Finland
2023 Rank: 129708
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Urology & Nephrology
Rank in SubField 1: 4969 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 129708 | 145458 |
| Total Cites | 9998 | 11134 |
| H-index | 48 | 49 |
| Hm-index | 15 | 15 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 23 | 23 |
| Number of Single+First Authored Papers | 51 | 51 |
| Total Cites to Single+First Authored Papers | 491 | 519 |
| Number of Single+First+Last Authored Papers | 155 | 155 |
| Total Cites to Single+First+Last Authored Papers | 2937 | 3150 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 9223 | 10019 |
| Ratio of Total Citations to Distinct Citing Papers | 1.08 | 1.11 |
| Self-Citation Percentage |
10.20%
|
|
Kellokumpu-Lehtinen, Pirkko Liisa
University Hospital of Tampere,
Finland
2022 Rank: 129115
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Urology & Nephrology
Rank in SubField 1: 4938 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 129115 | 144816 |
| Total Cites | 8897 | 9903 |
| H-index | 44 | 46 |
| Hm-index | 14 | 15 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 23 | 23 |
| Number of Single+First Authored Papers | 51 | 51 |
| Total Cites to Single+First Authored Papers | 455 | 480 |
| Number of Single+First+Last Authored Papers | 150 | 150 |
| Total Cites to Single+First+Last Authored Papers | 2723 | 2923 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 8234 | 8949 |
| Ratio of Total Citations to Distinct Citing Papers | 1.08 | 1.11 |
| Self-Citation Percentage |
10.16%
|
|
Kellokumpu-Lehtinen, Pirkko Liisa
University Hospital of Tampere,
Finland
2021 Rank: 127122
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Urology & Nephrology
Rank in SubField 1: 4901 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 127122 | 140583 |
| Total Cites | 8402 | 9341 |
| H-index | 44 | 46 |
| Hm-index | 14 | 14 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 23 | 23 |
| Number of Single+First Authored Papers | 51 | 51 |
| Total Cites to Single+First Authored Papers | 434 | 459 |
| Number of Single+First+Last Authored Papers | 150 | 150 |
| Total Cites to Single+First+Last Authored Papers | 2628 | 2819 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7782 | 8456 |
| Ratio of Total Citations to Distinct Citing Papers | 1.08 | 1.10 |
| Self-Citation Percentage |
10.05%
|
|